Skip to content
Search

Latest Stories

iGAS: David Webb asks pharmacies to order antibiotics ‘sensibly’

With  higher than usual number of cases of scarlet fever, caused by invasive Group A streptococci (iGAS) infections being reported in children across the country, Chief Pharmaceutical Officer for England David Webb has assured pharmacies of sufficient supply of antibiotics.

In a letter, shared by the PDA, Webb also urged the pharmacies to order antibiotic stocks sensibly.


“Local pharmacy teams may be experiencing a temporary interruption of supply of some relevant antibiotics due to increased demand. On a national level, sufficient stock exists for the NHS,” he said.

He said NHS is working closely with the Department of Health and Social Care (DHSC) and has taken actions to help ensure medicines continue to be available.

He explained that the supplies of antibiotics for the treatment of Group A Strep, particularly phenoxymethylpenicillin presentations, have seen a surge in demand, leading to potential constraints at certain wholesalers and pharmacies,

“Supplies are readily available with manufacturers and deliveries into wholesalers and pharmacies are being expedited and are expected in the coming days,” he added.

Where antibiotic therapy is required for the treatment of suspected GAS infection, he asked prescribers and local pharmacy teams to “work together to understand availability of antibiotics locally and order antibiotic stocks sensibly, in line with patient demand,” ensuring that excessive quantities are not ordered to avoid more pressure on the supply chain.

He also urged pharmacy teams to reassure worried parents and carers, as well as patients, and display the guidance available at NHS website prominently on site.

In a statement today (9 December), the RPS has also noted that pharmacists and teams are working hard to resolve stock issues around antibiotics.

“The situation around rising cases of Strep A and obtaining antibiotics has been challenging for patients, parents and carers, pharmacists and all those in our health system working to help patients,” Professor Claire Anderson, RPS president, and Thorrun Govind, Andrew Carruthers and Cheryl Way, chairs of the body in England, Scotland and Wales respectively, said in a joint statement.

“Thank you to all pharmacists and pharmacy technicians working hard to resolve stock issues around antibiotics needed to treat Strep A. We know you’re under enormous pressure and doing everything you can to keep patients well. Your professionalism in the face of adversity and determination to put patients first is always inspiring but we recognize often comes at a personal cost to your wellbeing.

“We are in contact with the NHS and governments across Great Britain and doing all we can to support you to help patients. The situation is under constant review and the aim of everyone is to ensure patients get access to the medicines they need.”

Earlier, PSNC has said that its Dispensing and Supply Team has received reports from some contractors and pharmacy teams who are finding it difficult to obtain certain antibiotics.

“Pharmacy teams are reporting that there is little or no stock of liquid amoxicillin and phenoxymethylpenicillin (Pen V) showing at wholesalers, and that the supply challenges have now extended to other oral antibiotics too. PSNC is also monitoring prices for these medicines and is seeking concessionary prices based on reports received from contractors,” it said.

The Healthcare Distribution Association has confirmed that the huge spike in demand for several antibiotics, adding that its members are working hard with manufacturers to increase supply to meet this unprecedented demand.

On Wednesday, Alliance Healthcare issued the following update: “Working with the healthcare industry Alliance Healthcare works closely with manufacturers to ensure maximum supply of product to UK patients. Demand has been high across our antibiotics range recently and despite generally good supply levels, we are experiencing some short-term impact as a result, however more replenishment is on the way. We ask that our customers only buy what they need and continue to regularly check myahportal.co.uk for the most up to date stock availability information.”

Misinformation

Meanwhile, the PSNC has flagged some misinformation that has been spreading on social media about the help that community pharmacies can provide.

A suggestion has been made that pharmacies can test for strep A and hand out antibiotics, but this is not an NHS service and is only provided by a small number of pharmacies privately and under specific PGDs or where independent prescribers are available, it noted.

“PSNC is pushing DHSC and NHS England to address these misconceptions and put out clear communications on where parents should go for help and where pharmacy teams should direct people to,” the organization said.

PSNC asked pharmacies to make use of the social media resources developed by the UKHSA, available to download from the DHSC campaign resources center, to raise awareness amongst the public.

It also highlighted the guide published by the Specialist Pharmacy Service (SPS) on using solid oral dosage form antibiotics in children, including use for Group A streptococcal infections.

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less